| Associate or Manager, PHAD Japan |
Toranomon (NPKK Head Office) |
Japan |
Development |
Development |
Research & Development |
03. Februar 2026 |
| Associate Country Procurement |
Sasayama |
Japan |
Operations |
Production / Manufacturing |
Beschaffung |
03. Februar 2026 |
| Associate Country Procurement |
Sasayama |
Japan |
Operations |
Production / Manufacturing |
Beschaffung |
03. Februar 2026 |
| Associate, Country QA Operations, Products, ATMP |
Toranomon (NPKK Head Office) |
Japan |
Operations |
Quality |
Quality |
29. Januar 2026 |
| Associate, Country QA Compliance |
Toranomon (NPKK Head Office) |
Japan |
Operations |
Quality |
Quality |
23. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Director, Policy |
Toranomon (NPKK Head Office) |
Japan |
International |
Other |
Communications & Public Affairs |
22. Januar 2026 |
| Senior Lead or Lead, Public Affairs |
Toranomon (NPKK Head Office) |
Japan |
International |
Other |
Communications & Public Affairs |
22. Januar 2026 |
| Director, Social Impact & Novartis Foundation (Japan) for the Promotion of Science |
Toranomon (NPKK Head Office) |
Japan |
International |
Other |
Communications & Public Affairs |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) |
Yokohama |
Japan |
International |
Sales |
Der Umsatz |
22. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Medical Representative, Solid Tumor (Nagoya) |
Nagoya |
Japan |
International |
Sales |
Der Umsatz |
20. Januar 2026 |
| Senior Statistical Programmer |
Toranomon (NPKK Head Office) |
Japan |
Development |
Development |
Research & Development |
19. Januar 2026 |
| Senior Statistical Programmer |
Toranomon (NPKK Head Office) |
Japan |
Development |
Development |
Research & Development |
19. Januar 2026 |
| Head, Corporate Comms |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
Communications |
Communications & Public Affairs |
06. Januar 2026 |
| Sr Manager, Executive Communications |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
Communications |
Communications & Public Affairs |
18. Dezember 2025 |
| Clinical Development Director Japan |
Toranomon (NPKK Head Office) |
Japan |
Development |
Development |
Research & Development |
15. Dezember 2025 |
| Associate, QA Officer Operations |
Sasayama |
Japan |
Operations |
Quality |
Quality |
07. Dezember 2025 |
| Associate, RLT Lab Technician |
Sasayama |
Japan |
Operations |
Quality |
Quality |
18. November 2025 |
| Japan Program Head (Oncology) |
Toranomon (NPKK Head Office) |
Japan |
Development |
Development |
Research & Development |
17. November 2025 |
| Investigation Expert |
Sasayama |
Japan |
Operations |
Quality |
Quality |
14. November 2025 |
| 【契約社員】Associate, General Affairs |
Toranomon (NPKK Head Office) |
Japan |
International |
General Management |
Einrichtungen und Verwaltung |
06. November 2025 |
| Associate or Manager, Japan Program Clinical Head |
Toranomon (NPKK Head Office) |
Japan |
Development |
Development |
Research & Development |
06. November 2025 |
| SCM Material Planner (RLT) |
Sasayama |
Japan |
Operations |
Production / Manufacturing |
Technical Operations |
28. Oktober 2025 |
| MS&T Lead, RLT Sasayama |
Sasayama |
Japan |
Operations |
Production / Manufacturing |
Technical Operations |
13. Oktober 2025 |
| PU Lead RLT Sasayama |
Sasayama |
Japan |
Operations |
Production / Manufacturing |
Technical Operations |
13. Oktober 2025 |
| Expression of Interest: Medical Affairs Talent |
Toranomon (NPKK Head Office) |
Japan |
|
|
Research & Development |
30. September 2025 |
| Japan Program Head (Immunology) |
Toranomon (NPKK Head Office) |
Japan |
Development |
Development |
Research & Development |
24. April 2025 |